ThisWeekinFM reports on the launch of Intelligent Fingerprinting’s fingerprint-based drug screening system and explains how the new test provides a hygienic and dignified means of supporting a wide range of workplace drug testing scenarios – from pre-employment screens and random drug tests to post-accident investigations.
Drug misuse is a serious concern when it comes to health and safety in the workplace – particularly in those safety-critical environments where transport operators are responsible for HGV, PSV or LCV vehicles and their cargos or passengers. In this article, Transport Operator examines the role and management of drug screening in the workplace for commercial transport operators and considers if there is a better way.
Business Weekly reports on the three-year deal between Intelligent Fingerprinting and UK medical device manufacturing specialist Europlaz to produce critical components for the innovative cartridge element of the company’s new fingerprint drug screening system.
Digital Health reports that following a successful trial, HM Senior Coroner for Staffordshire (South) has placed an order for a new fingerprint-based drug screening system from Intelligent Fingerprinting. The new technology will be used by the Coroner’s team to carry out a simple, non-invasive drug test on the deceased immediately upon arrival at the mortuary. The test results will help to prioritise costly and time-consuming post-mortem investigations.
Reporting on the launch of Intelligent Fingerprinting’s fingerprint sweat drug test, the Evening Standard explains how the new technology could be used by employers, hospitals, prisons and coroners to screen for cocaine, opiate, cannabis and amphetamine use, with accuracy levels comparable to conventional urine tests.
MailOnline reports on the launch of the world’s first portable fingerprint drug test from Intelligent Fingerprinting which analyses fingerprint sweat to detect recent drug use. The article focuses on the technology’s potential for fingerprint drug tests to facilitate workplace drug screening programmes, which are currently reliant on the collection of urine or saliva samples. It also describes applications for fingerprint drug testing in courts, drug rehabilitation and coroner services. In contrast to conventional drug tests, the fingerprint drug test from Intelligent Fingerprinting is quick and easy to collect, providing drug screening results for opiates, cocaine, amphetamines and cannabis within 10 minutes.
The Times reports that the first portable fingerprint-based drug test – developed by Cambridge-based Intelligent Fingerprinting – has gone on sale. It explains that the new drug screening system detects use of recreational substances in under 10 minutes and costs only a few pounds per test. Target markets for Intelligent Fingerprinting include prisons, hospitals, coroners and safety-critical workplaces.
Cambridge News reports on the recent trial of Intelligent Fingerprinting’s fingerprint drug testing system by the Norfolk Recovery Partnership (NRP), an organisation that provides advice and treatment for adults with drug and alcohol problems across Norfolk. The news article explains that during the trial NRP found that fingerprint-based drug screening was particularly easy to use, with none of the hygiene or administrative issues typically associated with traditional drug screening methods that use saliva or urine.
The article quotes Christopher Strivens, deputy service manager for NRP: “With Intelligent Fingerprinting there’s now a drug screening approach that is both non-invasive and easy to use. Fingerprint-based screening certainly looks like it will prove a valuable technology for use by drug rehabilitation services.”
Read the article (on the Cambridge News website).
EDP24 reports that Intelligent Fingerprinting, the University of East Anglia spin-out company pioneering the development of fingerprint drug screening, has raised £3m for the next stage of its development.
Pharmafile reports on Intelligent Fingerprinting’s £3m funding boost to support the development of its portable drug screening technology.
